Presentation of VivaSant

- 3 -

A Family Group Focused on Long-Term Growth and International Development

BTG Industries & Sant is a French family office fully owned by the Le Lous family

The business traces its origins in 1949 when Jean Le Lous becomes the Chairman of Laboratoires Fournier Sarl, that will turn in less than 50 years the 4th independent pharmaceutical player in France

Soon enough in 1958, operations of the Group were divided in two core businesses: Fournier Pharma, the ethical division Laboratoires Urgo, that will become leader in wound treatment

In 2006, VivaSant divested Fournier Pharma to Solvay Group and re-

centered its activities on 2 poles: Advanced Wound Management Self-Medication

H. Le Lous Chairman

C. Arend CFO

P. Moustial COO

- 4 -

The DNA of VivaSant VivaSant has a corporate culture underpinned by its DNA, at the center is Innovation

Entrepreneurship

Adaptability

Excellence

Consumer focus

Innovation

We encourage entrepreneurs initiatives and audacity. We strongly believe that to succeed, you should test, try and think out of the box

Consumer is the cornerstone of our business. We work

continuously with one objective: to bring the most

suitable answers to his needs and ailments

Offering best in class products, looking for a

number 1 position

To succeed worldwide, to maintain a leading position on our markets, we have to be flexible and to keep our eyes and ears open

- 5 -

VivaSant Group structure Four business units generating 520M worldwide

2013 sales : 517 M

2 200 people

2011 : 109M 2011 : 118M 2011 : 31M

350 people 180 people

Pharmacies Retail, Mass Market

Hospital & Community Natural Health & herbal medicine

Speciality Care Consumer Healthcare

194M 34M 126M

163M

1650 people

- 6 -

Urgo Medical N3 on the European Advanced Wound Care Market

Urgo medical provides gold standard dressings for the treatment of serious incapacitating solutions : Burns Leg ulcers Epidermolysis bullosa Diabetic foot ulcers Pressure sores

Starting this activity in 2000, Urgo Medical revolutionised

the wound healing market by inventing UrgoTul , a dressing based on the Technology Lipido Colloid (TLC) for the management of acute and chronic wounds : Healing in a moist environment Promoting fibroblast proliferation Easy to remove with pain-free dressing changes Protecting and improving the surrounding skin Now most prescribed product on the European Advanced

Wound Care market

- 7 -

A the heart of Urgo Medical success: the TLC Technology A unique combination of hydrocolloid and lipid particles on a non-occlusive polyester mesh

- 8 -

Urgo Medic was then developed as the booster version of TLC for diabetic, arteritic and venous insufficient patients: NOSF component designed to neutralize excess proteases,

therefore rebalancing wound equilibrium and accelerating wound healing

Urgo Start benefited from the first-ever comparative randomised, controlled, double-blind study, which showed that UrgoStart speeds up wound healing X2

In 2011, we launched UrgoClean , an ultra-absorbent dressing with hydro-desloughing fibres for sloughy exuding wounds: Clean the wound, absorbs exudates and traps slough

Traps bacteria

Urgo Medical N3 on the European Advanced Wound Care Market

- 9 -

Urgo Medical Strategy: to have one dressing for each requirement

Thanks to this strategy and commitment, Urgo Medical became in less than 10 years N1 in France and N 3 on the European Advanced Wound Care market

- 10 -

Humex - Humer The Specialist of Ear Nose and Throat pathologies

2 leading brands: Humex and Humer

Best in class products for treatment of upper respiratory track disorders

OTC and Medical Devices status

N1 in France on the allergy market

Strong presence in Romania, Ukraine, Baltic States and North Africa

Allergies, hay fever,

allergic rhinitis, allergic

conjunctivitis

Complete range for cold

treatment, cough, sore

throats and flu-like symptom

Cough & Cold

Allergies

The very best of the sea water

for ear/nose hygiene and

nasal decongestion

Sea Water Spray

85% brand awareness

Distribution in pharmacies

- 11 -

Urgo & Mercurochrome N1 in France in first aid and wound treatment

Mercurochrome: 98% brand awareness in France. N1 in modern trade and mass market

Urgo: 85% brand awareness in France. N1 in pharmacies

Through these 2 brands, VivaSant built a solid reputation in wound care, revolutionising the traditional dressings market with innovative forms, such as its Filmogel (liquid dressing), and expanding its treatment ranges to include mouth wounds, pain relief and support

Voted most innovative OTC pharmaceutical company by pharmacists 3 years in succession

Strong presence in Portugal, Spain, Baltic States and Vietnam

Liquid plasters and dedicated solutions for

skin cracks, cold sores, damaged

nails, scars and mouth ulcers

Mouthcare, Hand & Foot

First-aid:

Plasters & Antiseptics

Leading brand for

wound care

- 12 -

Juvamine and Alvityl Prevention and Nutrition expertise

pioneer of dietary supplements products in mass market (multivitamins, Omega 3, nutrition, herbal products, etc.).

Leading brand in French supermarkets with more than 60% market shares

complex of multivitamins prescribed and recommended by paediatricians

Several other brands for well-being: OM3, Immunostim

Balance, energy, Vitamins & Minerals, Slimming and

Herbal therapy

93% brand awareness

Health Immune defences Balance & energy

Prevention & Nutrition Health

Food supplements

- 13 -

Super Diet Specialist in natural and organic products for self-prescription

Dietary supplement with natural and organic active principles Major brands in phytotherapy, natural medication and self-medication High-end products (clinical studies, highly concentrated products, easy to use) Products sold in pharmacies, organic and dietetic shops

Distribution in specialised stores

- 14 -

Our leading positions in France in short

- 15 -

The success stories of our brands around the world

Vietnam

Czech Republic

Algeria Belgium Vietnam Ukraine Baltic States Romania Algeria

N1 on traditional plasters (over 2M sales)

N1 on blister plasters with 48,5% MS

More than 100Ku of Urgo Mouth Ulcer sold in 2012. 98% brand awareness among pharmacists 93% brand awareness among pharmacists N2 with over 200ksales (launch in 2010) More than 1Mn units sold in 2012 with 48% MS N1 on the sea water market N2 on the sea water and cough & cold market N1 with 36,2% MS 41% brand awareness amoung consumers 99% brand awareness among GPs

- 21 -

VivaSant in summary

France is a land of excellence for healthcare. A network of researchers in all our fields of interest, highly efficient healthcare institutions and a firmly established industrial tradition form the fundations on which VivaSant has built its success

Every man and woman working at VivaSant is firmly committed to safety and efficacy of our product lines. Our shared determination is to have recognized solutions to each ailment of the day to day life and to be in each country where we enter, the partner for health of every patient